Cholera Vaccines Market Size To Reach $163.4 Million By 2030

Cholera Vaccines Market Growth & Trends

The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

 Request a free sample copy or view report summary: Cholera Vaccines Market Report

Cholera Vaccines Market Report Highlights

• The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030

• By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable

• The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects

• North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination

Cholera Vaccines Market Segmentation

Grand View Research has segmented the global cholera vaccine market report based on type, product, distribution channel, and region:

Cholera Vaccines Type Outlook (Revenue, USD Million, 2018 - 2030)

• Whole Cell v. Cholerae O1 with Recombinant B- subunit

• Killed Oral O1 and O139

Cholera Vaccines Product Outlook (Revenue, USD Million, 2018 - 2030)

• Vaxchora

• Dukoral

• Shanchol

• Other products

Cholera Vaccines Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy

• Retail Pharmacy

• Other

Cholera Vaccines Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Cholera Vaccines Market

• Valneva SE

• Sanofi S.A.

• Emergent BioSolutions Inc.

• PaxVax Inc.

• EuBiologics Co., Ltd.

• Shantha Biotechnics Limited

• Hilleman Laboratories

• Astellas Pharma Inc.

• Incepta Vaccine Ltd.

• Vabiotech